Home BP Telemonitoring, Pharmacist Management: Does It Up Adherence?
According to a study published in the Journal of Clinical Pharmacy and Therapeutics, medication adherence was high in hypertensive patients who received home blood pressure (BP) telemonitoring and pharmacist management but adherence levels were not significantly altered by the intervention.
A team-based approach with home BP monitoring can be an effective initiative to improve uncontrolled hypertension. P.A. Pawloski, PharmD, and colleagues from HealthPartners Institute, Minneapolis, MN, and Group Health Research Institute, Seattle, WA, conducted a study (n=240) to evaluate whether objectively measured medication adherence was impacted by home BP telemonitoring and pharmacist management.
The study authors analyzed hypertension medication adherence in patients who received home BP and pharmacist intervention. Adherence was assessed based on prescription fills and the proportion of days covered. The results showed more hypertension medications were discontinued pre- to post-baseline in telemonitoring intervention patients compared to usual care patients (rate ratio [RR] 1.38; P=0.04). In addition, more hypertension medications were added for patients who received intervention (RR 2.46; P<0.001).
Dr. Pawloski concluded that though medication adherence was not significantly changed by the intervention, more modifications and greater medication intensification was seen among telemonitoring and pharmacist intervention patients.
For more information visit onlinelibrary.wiley.com.